Immunogenicity of anti-rabies vaccines (ARVs) marketed in Sri Lanka: a comparative study
Clinical and Experimental Vaccine Research · 2026 · 15 (2) · 151
DOI: 10.7774/cevr.2026.15.e13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Vaccine Research, 2026. Verfasst von Hasanthi Rathnadiwakara und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and the 3Rs Centre for Laboratory Animal Science, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Boehringer Ingelheim.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology and the 3Rs Centre for Laboratory Animal Science, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
- EU/WOAH/WHO Reference Laboratory for Rabies, OMCL for Rabies Vaccines, ANSES-Nancy, Nancy, France.
- JC&P Life Science Partners, Forcalquier, France.
- Animal Centre, Medical Research Institute, Colombo, Sri Lanka.
- Municipal Veterinary Department, Colombo Municipal Council, Colombo, Sri Lanka.
- Department of Community Medicine, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
ORCID-Profile: Hasanthi Rathnadiwakara, Florence Cliquet, Marine Wasniewski, Jean-Christophe Thibault, Jean-Luc Schereffer, Mayuri Thammitiyagodage, Mohamed Ijas, Dulani Samaranayake, Mangala Gunatilake
Förderung
- Boehringer Ingelheim
Zitieren
APA
Rathnadiwakara, H., Cliquet, F., Wasniewski, M., Thibault, J. C., Schereffer, J. L., Thammitiyagodage, M., Ijas, M., Samaranayake, D., & Gunatilake, M. (2026). Immunogenicity of anti-rabies vaccines (ARVs) marketed in Sri Lanka: a comparative study. Clinical and Experimental Vaccine Research, 15(2), 151. https://doi.org/10.7774/cevr.2026.15.e13
Vancouver
Rathnadiwakara H, Cliquet F, Wasniewski M, Thibault JC, Schereffer JL, Thammitiyagodage M, et al. Immunogenicity of anti-rabies vaccines (ARVs) marketed in Sri Lanka: a comparative study. Clinical and Experimental Vaccine Research. 2026;15(2):151. doi:10.7774/cevr.2026.15.e13
BibTeX
@article{Rathnadiwakara2026,
author = {Rathnadiwakara, Hasanthi and Cliquet, Florence and Wasniewski, Marine and Thibault, Jean-Christophe and Schereffer, Jean-Luc and Thammitiyagodage, Mayuri and Ijas, Mohamed and Samaranayake, Dulani and Gunatilake, Mangala},
title = {Immunogenicity of anti-rabies vaccines (ARVs) marketed in Sri Lanka: a comparative study},
journal = {Clinical and Experimental Vaccine Research},
year = {2026},
volume = {15},
number = {2},
pages = {151},
doi = {10.7774/cevr.2026.15.e13}
}
EUVIMED